Literature DB >> 9737515

Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk.

M J Stevens1, D M Raffel, K C Allman, F Dayanikli, E Ficaro, T Sandford, D M Wieland, M A Pfeifer, M Schwaiger.   

Abstract

BACKGROUND: Regional cardiac sympathetic hyperactivity predisposes to malignant arrhythmias in nondiabetic cardiac disease. Conversely, however, cardiac sympathetic denervation predicts increased morbidity and mortality in severe diabetic autonomic neuropathy (DAN). To unite these divergent observations, we propose that in diabetes regional cardiac denervation may elsewhere induce regional sympathetic hyperactivity, which may in turn act as a focus for chemical and electrical instability. Therefore, the aim of this study was to explore regional changes in sympathetic neuronal density and tone in diabetic patients with and without DAN. METHODS AND
RESULTS: PET using the sympathetic neurotransmitter analogue 11C-labeled hydroxyephedrine ([11C]-HED) was used to characterize left ventricular sympathetic innervation in diabetic patients by assessing regional disturbances in myocardial tracer retention and washout. The subject groups comprised 10 diabetic subjects without DAN, 10 diabetic subjects with mild DAN, 9 diabetic subjects with severe DAN, and 10 healthy subjects. Abnormalities of cardiac [11C]-HED retention were detected in 40% of DAN-free diabetic subjects. In subjects with mild neuropathy, tracer defects were observed only in the distal inferior wall of the left ventricle, whereas with more severe neuropathy, defects extended to involve the distal and proximal anterolateral and inferior walls. Absolute [11C]-HED retention was found to be increased by 33% (P<0.01) in the proximal segments of the severe DAN subjects compared with the same regions in the DAN-free subjects (30%; P<0.01 greater than the proximal segments of the mild DAN subjects). Despite the increased tracer retention, no appreciable washout of tracer was observed in the proximal segments, consistent with normal regional tone but increased sympathetic innervation. Distally, [11C]-HED retention was decreased in severe DAN by 33% (P<0.01) compared with the DAN-free diabetic subjects (21%; P<0.05 lower than the distal segments of the mild DAN subjects).
CONCLUSIONS: Diabetes may result in left ventricular sympathetic dysinnervation with proximal hyperinnervation complicating distal denervation. This combination could result in potentially life-threatening myocardial electrical instability and explain the enhanced cardioprotection from beta-blockade in these subjects.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737515     DOI: 10.1161/01.cir.98.10.961

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  56 in total

Review 1.  Cardiac receptor physiology and its application to clinical imaging: present and future.

Authors:  H Tseng; J M Link; J R Stratton; J H Caldwell
Journal:  J Nucl Cardiol       Date:  2001 May-Jun       Impact factor: 5.952

2.  Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Authors:  Berlinda J van der Veen; Imad Al Younis; Albert de Roos; Marcel P M Stokkel
Journal:  J Nucl Cardiol       Date:  2012-06-06       Impact factor: 5.952

Review 3.  Radionuclide imaging of cardiac autonomic innervation.

Authors:  Sang Yong Ji; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 4.  What do we know and we do not know about cardiovascular autonomic neuropathy in diabetes.

Authors:  Rodica Pop-Busui
Journal:  J Cardiovasc Transl Res       Date:  2012-05-30       Impact factor: 4.132

Review 5.  Role of PET in the evaluation and understanding of coronary physiology.

Authors:  Thomas H Schindler; Xiao-Li Zhang; Gabriella Vincenti; Leila Mhiri; René Lerch; Heinrich R Schelbert
Journal:  J Nucl Cardiol       Date:  2007-07       Impact factor: 5.952

6.  Quantitation of cardiac sympathetic innervation in rabbits using 11C-hydroxyephedrine PET: relation to 123I-MIBG uptake.

Authors:  Yusuke Nomura; Ichiro Matsunari; Hiroyuki Takamatsu; Yoshihiro Murakami; Takahiro Matsuya; Junichi Taki; Kenichi Nakajima; Stephan G Nekolla; Wei-Ping Chen; Kouji Kajinami
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-05-24       Impact factor: 9.236

Review 7.  Autonomic aspects of arrhythmogenesis: the enduring and the new.

Authors:  Richard L Verrier; Charles Antzelevitch
Journal:  Curr Opin Cardiol       Date:  2004-01       Impact factor: 2.161

Review 8.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

9.  Norepinephrine release is reduced in cardiac tissue of Type 2 diabetic patients.

Authors:  C Burgdorf; D Richardt; T Kurz; S Adler; A Nötzold; E G Kraatz; H H Sievers; G Richardt
Journal:  Diabetologia       Date:  2003-03-22       Impact factor: 10.122

10.  Diabetic cardiomyopathy: ongoing controversies in 2012.

Authors:  P M Seferović; I Milinković; A D Ristić; J P Seferović Mitrović; K Lalić; A Jotić; V Kanjuh; N Lalić; B Maisch
Journal:  Herz       Date:  2012-12       Impact factor: 1.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.